These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Macrocyclic Compounds from Ansamycin Antibiotic Class as Inhibitors of PD1-PDL1 Protein-Protein Interaction. Patil SP; Yoon SC; Aradhya AG; Hofer J; Fink MA; Enley ES; Fisher JE; Herb MC; Klingos A; Proulx JT; Fedorky MT Chem Pharm Bull (Tokyo); 2018; 66(8):773-778. PubMed ID: 30068796 [TBL] [Abstract][Full Text] [Related]
6. Target-Specific Machine Learning Scoring Function Improved Structure-Based Virtual Screening Performance for SARS-CoV-2 Drugs Development. Tahir Ul Qamar M; Zhu XT; Chen LL; Alhussain L; Alshiekheid MA; Theyab A; Algahtani M Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232307 [TBL] [Abstract][Full Text] [Related]
7. A practical guide to machine-learning scoring for structure-based virtual screening. Tran-Nguyen VK; Junaid M; Simeon S; Ballester PJ Nat Protoc; 2023 Nov; 18(11):3460-3511. PubMed ID: 37845361 [TBL] [Abstract][Full Text] [Related]
8. Integration of cancer stemness and neoantigen load to predict responsiveness to anti-PD1/PDL1 therapy. Luo K; Liu S; Shen X; Xu J; Shi C; Chao Y; Wen Z; Zhang K; Wang R; Liu B; Jiang Y Front Cell Dev Biol; 2022; 10():1003656. PubMed ID: 36467413 [No Abstract] [Full Text] [Related]
9. Evaluation of PD1/PDL1 Expression and Their Clinicopathologic Association in EBV-associated Lymphoproliferative Disorders in Nonimmunosuppressed Patients. Guo L; Bodo J; Durkin L; Hsi ED Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):101-106. PubMed ID: 29084057 [TBL] [Abstract][Full Text] [Related]
10. Identification of PDL1-Related Biomarkers to Select Lung Adenocarcinoma Patients for PD1/PDL1 Inhibitors. Wu Y; Lin L; Liu X Dis Markers; 2020; 2020():7291586. PubMed ID: 32587640 [TBL] [Abstract][Full Text] [Related]
11. Recognition of PDL1/L2 by different induced-fit mechanisms of PD1: a comparative study of molecular dynamics simulations. Lyu N; Wang K; Zhang F; Qin H; Zhao Y; Wu R; Si Y; Wang L Phys Chem Chem Phys; 2020 Jan; 22(3):1276-1287. PubMed ID: 31850422 [TBL] [Abstract][Full Text] [Related]
12. Predicting a Stable Dimeric Form of the PD1-PDL1 Complex: Implications for Understanding the PD1 Activation Mechanism. Ponce LF; Ramírez-Echemendia DP; León K; Valiente PA J Phys Chem B; 2023 Jul; 127(26):5764-5771. PubMed ID: 37343227 [TBL] [Abstract][Full Text] [Related]
13. Expanded human NK cells from lung cancer patients sensitize patients' PDL1-negative tumors to PD1-blockade therapy. Poznanski SM; Ritchie TM; Fan IY; El-Sayes A; Portillo AL; Ben-Avi R; Rojas EA; Chew MV; Shargall Y; Ashkar AA J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479024 [TBL] [Abstract][Full Text] [Related]
14. Research Trends and Most Influential Clinical Studies on Anti-PD1/PDL1 Immunotherapy for Cancers: A Bibliometric Analysis. Liu Y; Xu Y; Cheng X; Lin Y; Jiang S; Yu H; Zhang Z; Lu L; Zhang X Front Immunol; 2022; 13():862084. PubMed ID: 35493449 [TBL] [Abstract][Full Text] [Related]
16. Performance of machine-learning scoring functions in structure-based virtual screening. Wójcikowski M; Ballester PJ; Siedlecki P Sci Rep; 2017 Apr; 7():46710. PubMed ID: 28440302 [TBL] [Abstract][Full Text] [Related]
17. Proton beam radiotherapy combined with anti-PD1/PDL1 immune checkpoint inhibitors for advanced hepatocellular carcinoma. Su CW; Hou MM; Huang PW; Chou YC; Huang BS; Tseng JH; Hsu CW; Chang TC; Lin SM; Lin CC Am J Cancer Res; 2022; 12(4):1606-1620. PubMed ID: 35530291 [TBL] [Abstract][Full Text] [Related]
18. Trends in the Research Into Immune Checkpoint Blockade by Anti-PD1/PDL1 Antibodies in Cancer Immunotherapy: A Bibliometric Study. Sun Y; Jiang L; Wen T; Guo X; Shao X; Qu H; Chen X; Song Y; Wang F; Qu X; Li Z Front Pharmacol; 2021; 12():670900. PubMed ID: 34489691 [TBL] [Abstract][Full Text] [Related]
19. Flow Cytometry-Assessed PD1/PDL1 Status in Tumor-Infiltrating Lymphocytes: A Link With the Prognosis of Diffuse Large B-Cell Lymphoma. Chen Z; Deng X; Ye Y; Zhang W; Liu W; Zhao S Front Oncol; 2021; 11():687911. PubMed ID: 34211855 [TBL] [Abstract][Full Text] [Related]
20. Expression of PD1/PDL1 in gastric cancer at different microsatellite status and its correlation with infiltrating immune cells in the tumor microenvironment. Wang YL; Gong Y; Lv Z; Li L; Yuan Y J Cancer; 2021; 12(6):1698-1707. PubMed ID: 33613757 [No Abstract] [Full Text] [Related] [Next] [New Search]